Tradestie Institutional Equity Comparison Engine
KAVL vs ENSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENSC Overall Edge
ENSC Captures Institutional Edge (3โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, KAVL trades at N/M Forward P/E with -392.1% operating margin (-80.0% YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, KAVL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ENSC
KAVL N/M vs ENSC 0.8x Fwd P/E
Growth & Margin Winner
ENSC
Op Margin -392.1% vs -281.3% ยท YoY -80.0% vs -15.1%
Momentum & Technical Winner
ENSC
1Y -83.9% vs -80.3% ยท 52W Pos 1% vs 8%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KAVL
NASDAQ
Kaival Brands Innovations Group, Inc
Retail-Nonstore Retailers
$0.14
-12.96% 1D
Market Cap
$1.8M
1M Return
-71.05%
1Y Return
-83.86%
Forward P/E
N/M
Unified AI Score
49.1 / 100
HOLD
Tech 40.0
Fund 49.0
Flow 50.0
Mom 63.9
ENSC
NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap
$7.0M
1M Return
-29.55%
1Y Return
-80.33%
Forward P/E
0.8x
Unified AI Score
53.4 / 100
HOLD
Tech 50.0
Fund 62.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
KAVL -83.86%
ENSC -80.33%
Spread: +35.81 pp (ENSC Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | KAVL Revenue | ENSC Revenue | KAVL Op. Margin | ENSC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $60M | $0M | 2.8% | -41.0% | KAVL |
| FY2021 | $60M | $0M | 6.8% | -562.7% | KAVL |
| FY2022 | $10M | $0M | 35.3% | -959.9% | KAVL |
| FY2023 | $10M | $0M | 181.9% | -480.5% | KAVL |
| FY2024 | $10M | $10M | 432.7% | -129.2% | KAVL |
| FY2025 | $0M | $10M | -3431.2% | -202.1% | ENSC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KAVL | ENSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.8M | $7.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | -80.0% | -15.1% | Higher Growth | ENSC |
| Operating Margin (TTM) Profitability | -392.1% | -281.3% | Higher Margin | ENSC |
| Net Profit Margin Profitability | 0.0% | -280.5% | Higher Margin | KAVL |
| Return on Equity (ROE) Capital Efficiency | -68.6% | -1295.1% | Higher ROE | KAVL |
| 52-Week Range Position Momentum | 1% ($0โ$2) | 8% ($0โ$2) | Stronger Trend | ENSC |
| Beta / 30D Volatility Risk Regime | 0.88ฮฒ ยท 244% Vol | 0.98ฮฒ ยท 79% Vol | Lower Realized Risk | ENSC |
| Unified Institutional Score Composite Signal | 49.1 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | ENSC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full KAVL vs ENSC Buy Guide
KAVL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ENSC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither KAVL nor ENSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.